Not applicableStudy completedNCT05572450What this trial is testingDose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge StrainWho this might be right forInfluenza A H1N1 Hvivo 70
Not applicableStudy completedNCT01178918What this trial is testingNon-specific Response to H1N1 VaccineWho this might be right forInfluenza H1N1 The University Clinic of Pulmonary and Allergic Diseases Golnik 14
Early research (Phase 1)Study completedNCT00724997What this trial is testingRandomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy VolunteersWho this might be right forSeasonal Human Influenza AVIR Green Hills Biotechnology AG 48
Not applicableStudy completedNCT05727202What this trial is testingProject STARFISH - PRJ0002679Who this might be right forSARS-CoV-2 InfectionInfluenza AInfluenza Type B+1 more Thermo Fisher Scientific, Inc 1,909
Large-scale testing (Phase 3)Ended earlyNCT03376321What this trial is testingEvaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A InfectionWho this might be right forInfluenza A Janssen Research & Development, LLC 334
Testing effectiveness (Phase 2)Study completedNCT02423577What this trial is testingSafety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge StrainWho this might be right forInfluenza Autoimmune Technologies, LLC 79
Testing effectiveness (Phase 2)Study completedNCT02213354What this trial is testingH7N9 Mix and Match With MF59 in Healthy Elderly PersonsWho this might be right forAvian Influenza National Institute of Allergy and Infectious Diseases (NIAID) 479
Testing effectiveness (Phase 2)Study completedNCT00867139What this trial is testingTCAD vs. Monotherapy for Influenza A in Immunocompromised PatientsWho this might be right forInfluenza Fred Hutchinson Cancer Center 7
Testing effectiveness (Phase 2)UnknownNCT01894477What this trial is testingTreo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia in RemissionChronic Myelomonocytic LeukemiaMinimal Residual Disease+3 more Fred Hutchinson Cancer Center 102
Early research (Phase 1)Study completedNCT00973895What this trial is testingVRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years OldWho this might be right forInfluenza A Virus, H1N1 SubtypeNovel Swine-Origin National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT06191393What this trial is testingSARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory SettingsWho this might be right forSARS-CoV-2 InfectionInfluenza AInfluenza B Aptitude Medical Systems 614
Testing effectiveness (Phase 2)Study completedNCT00306995What this trial is testingSafety Study of Pandemic Candidate Influenza Vaccines in the Elderly PopulationWho this might be right forInfluenzaInfluenza Vaccines GlaxoSmithKline 385
Early research (Phase 1)UnknownNCT06046092What this trial is testingH7HLAII DNA Influenza VaccineWho this might be right forInfluenza APandemic Influenza Oslo University Hospital 27
Early research (Phase 1)Study completedNCT01609998What this trial is testingSeasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & AdolescentsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 75
Early research (Phase 1)Study completedNCT03472976What this trial is testingH5N1 With or Without Topical Aldara in Healthy AdultsWho this might be right forAvian InfluenzaInfluenza Immunisation National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Looking for participantsNCT07516418What this trial is testingStudy of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of AgeWho this might be right forRespiratory Syncytial Virus (RSV)Influenza A(H5N1) Sanofi 570
Testing effectiveness (Phase 2)Looking for participantsNCT06684379What this trial is testingStudy on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)Who this might be right forSARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more PEACHES BIOTECH 50
Post-approval studies (Phase 4)Study completedNCT03410862What this trial is testingEvaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With InfluenzaWho this might be right forInfluenza, Human michael macknin 87
Large-scale testing (Phase 3)Study completedNCT01428908What this trial is testingImmunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and ChildrenWho this might be right forGroup A, C Polysaccharide MeningitisType b Haemophilus Influenza Jiangsu Province Centers for Disease Control and Prevention 2,394
Not applicableStudy completedNCT00263900What this trial is testingTGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency UnitWho this might be right forInfluenzaRespiratory Syncytial Viruses University Hospital, Rouen 377